Naloxegol for treating opioid‑induced constipation

  • Technology appraisal guidance
  • TA345
  • Published: 
Download guidance (PDF)

1 Guidance

1.1 Naloxegol is recommended, within its marketing authorisation, as an option for treating opioid induced constipation in adults whose constipation has not adequately responded to laxatives.

  • An inadequate response is defined as opioid‑induced constipation symptoms of at least moderate severity in at least 1 of the 4 stool symptom domains (that is, incomplete bowel movement, hard stools, straining or false alarms) while taking at least 1 laxative class for at least 4 days during the prior 2 weeks.